248 related articles for article (PubMed ID: 34830234)
1. New Approaches to Assess Mechanisms of Action of Selective Vitamin D Analogues.
Pike JW; Meyer MB
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830234
[TBL] [Abstract][Full Text] [Related]
2. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
[TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.
Seuter S; Pehkonen P; Heikkinen S; Carlberg C
Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription.
Zella LA; Meyer MB; Nerenz RD; Lee SM; Martowicz ML; Pike JW
Mol Endocrinol; 2010 Jan; 24(1):128-47. PubMed ID: 19897601
[TBL] [Abstract][Full Text] [Related]
6. The mouse RANKL gene locus is defined by a broad pattern of histone H4 acetylation and regulated through distinct distal enhancers.
Martowicz ML; Meyer MB; Pike JW
J Cell Biochem; 2011 Aug; 112(8):2030-45. PubMed ID: 21465526
[TBL] [Abstract][Full Text] [Related]
7. Enhancers located in the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
Zella LA; Kim S; Shevde NK; Pike JW
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):435-9. PubMed ID: 17218097
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription.
Fretz JA; Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Sep; 20(9):2215-30. PubMed ID: 16613987
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone.
Meyer MB; Goetsch PD; Pike JW
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):136-41. PubMed ID: 20171278
[TBL] [Abstract][Full Text] [Related]
10. Molecular endocrinology of vitamin D on the epigenome level.
Carlberg C
Mol Cell Endocrinol; 2017 Sep; 453():14-21. PubMed ID: 28315703
[TBL] [Abstract][Full Text] [Related]
11. An enhancer 20 kilobases upstream of the human receptor activator of nuclear factor-kappaB ligand gene mediates dominant activation by 1,25-dihydroxyvitamin D3.
Nerenz RD; Martowicz ML; Pike JW
Mol Endocrinol; 2008 May; 22(5):1044-56. PubMed ID: 18202151
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of Enhancer-mediated Hormonal Control of Vitamin D Receptor Gene Expression in Target Cells.
Lee SM; Meyer MB; Benkusky NA; O'Brien CA; Pike JW
J Biol Chem; 2015 Dec; 290(51):30573-86. PubMed ID: 26504088
[TBL] [Abstract][Full Text] [Related]
13. Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptor.
Pike JW; Meyer MB; Watanuki M; Kim S; Zella LA; Fretz JA; Yamazaki M; Shevde NK
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):389-95. PubMed ID: 17223545
[TBL] [Abstract][Full Text] [Related]
14. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of BMP2 by 1,25-dihydroxyvitamin D3 through DNA methylation and histone modification.
Fu B; Wang H; Wang J; Barouhas I; Liu W; Shuboy A; Bushinsky DA; Zhou D; Favus MJ
PLoS One; 2013; 8(4):e61423. PubMed ID: 23620751
[TBL] [Abstract][Full Text] [Related]
16. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S
J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639
[TBL] [Abstract][Full Text] [Related]
17. Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers.
Kim S; Yamazaki M; Zella LA; Shevde NK; Pike JW
Mol Cell Biol; 2006 Sep; 26(17):6469-86. PubMed ID: 16914732
[TBL] [Abstract][Full Text] [Related]
18. LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer.
Battaglia S; Karasik E; Gillard B; Williams J; Winchester T; Moser MT; Smiraglia DJ; Foster BA
Clin Epigenetics; 2017; 9():82. PubMed ID: 28811844
[TBL] [Abstract][Full Text] [Related]
19. Genomic Determinants of Vitamin D-Regulated Gene Expression.
Pike JW; Meyer MB; Benkusky NA; Lee SM; St John H; Carlson A; Onal M; Shamsuzzaman S
Vitam Horm; 2016; 100():21-44. PubMed ID: 26827947
[TBL] [Abstract][Full Text] [Related]
20. 1alpha,25-dihydroxy vitamin D3-enhanced expression of the osteocalcin gene involves increased promoter occupancy of basal transcription regulators and gradual recruitment of the 1alpha,25-dihydroxy vitamin D3 receptor-SRC-1 coactivator complex.
Carvallo L; Henríquez B; Paredes R; Olate J; Onate S; van Wijnen AJ; Lian JB; Stein GS; Stein JL; Montecino M
J Cell Physiol; 2008 Mar; 214(3):740-9. PubMed ID: 17786964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
